Gillian McGovern is an associate editor at Pharmacy Times®. She graduated from Rowan University in 2023 with a BA in Writing Arts and concentrations in Publishing & Writing for the Public, Technical & Professional Writing, and Creative Writing.
FDA Grants Approval to Generic Extended-Release Memantine/Donepezil and Everolimus
Published: January 23rd 2025 | Updated: January 23rd 2025Memantine/donepezil and everolimus are used to treat dementia of the Alzheimer type and tuberous sclerosis complex-associated subependymal giant cell astrocytoma, respectively.
Read More
Air Pollution and Seasonal Variability Associated With Asthma- and COPD-Related Hospital Admissions
January 20th 2025The authors found that humidity, cold and heat waves, and air pollution led to a higher likelihood of asthma- and chronic obstructive pulmonary disease (COPD)-related hospitalizations.
Read More
Study Shows Potential Population-Level Benefits of Intensive BP Targets in Adults With CKD
January 20th 2025The reduction in cardiovascular end points and the increase in adverse events observed in a clinical trial were largely transportable to trial-eligible chronic kidney disease (CKD) populations from clinical practice.
Read More
Pharmacists Can Help Patients Navigate Current Treatment Landscape of Alzheimer Disease
January 10th 2025The pharmacist’s role includes educating and making recommendations, collaborating with health care professionals, and observing early signs of cognitive impairment in patients during interactions.
Read More